Canada - English - Health Canada

patriot a division of janssen inc - norgestimate; ethinyl estradiol - tablet - 0.250mg; 0.035mg - norgestimate 0.250mg; ethinyl estradiol 0.035mg - contraceptives

Canada - English - Health Canada

patriot a division of janssen inc - oxybutynin chloride - tablet (extended-release) - 5mg - oxybutynin chloride 5mg - antimuscarinics

Canada - English - Health Canada

patriot a division of janssen inc - oxybutynin chloride - tablet (extended-release) - 10mg - oxybutynin chloride 10mg - antimuscarinics

Canada - English - Health Canada

patriot a division of janssen inc - oxybutynin chloride - tablet (extended-release) - 15mg - oxybutynin chloride 15mg - antimuscarinics

Canada - English - Health Canada

patriot a division of janssen inc - ethinyl estradiol; norgestimate; norgestimate; ethinyl estradiol; norgestimate; ethinyl estradiol - tablet - 0.025mg; 0.180mg; 0.215mg; 0.025mg; 0.250mg; 0.025mg - ethinyl estradiol 0.025mg; norgestimate 0.180mg; norgestimate 0.215mg; ethinyl estradiol 0.025mg; norgestimate 0.250mg; ethinyl estradiol 0.025mg - contraceptives

Canada - English - Health Canada

patriot a division of janssen inc - ethinyl estradiol; norgestimate; norgestimate; ethinyl estradiol; norgestimate; ethinyl estradiol - tablet - 0.025mg; 0.180mg; 0.215mg; 0.025mg; 0.250mg; 0.025mg - ethinyl estradiol 0.025mg; norgestimate 0.180mg; norgestimate 0.215mg; ethinyl estradiol 0.025mg; norgestimate 0.250mg; ethinyl estradiol 0.025mg - contraceptives

United States - English - NLM (National Library of Medicine)

patriot pharmaceuticals, llc - galantamine hydrobromide (unii: mj4ptd2vvw) (galantamine - unii:0d3q044kca) - galantamine 4 mg - galantamine er is indicated for the treatment of mild to moderate dementia of the alzheimer's type. galantamine er is contraindicated in patients with known hypersensitivity to galantamine hydrobromide or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of galantamine er or galantamine tablets in pregnant women. in studies conducted in animals, administration of galantamine during pregnancy resulted in developmental toxicity (increased incidence of morphological abnormalities and decreased growth in offspring) at doses similar to or greater than those used clinically (see data). in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. data animal data in rats, administration of galantamine (oral doses of 2, 8, or 16

United States - English - NLM (National Library of Medicine)

patriot pharmaceuticals, llc - paliperidone (unii: 838f01t721) (paliperidone - unii:838f01t721) - paliperidone 3 mg - paliperidone extended-release tablets are indicated for the treatment of schizophrenia [see clinical studies (14.1)] . the efficacy of paliperidone extended-release tablets in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents, as well as one maintenance trial in adults. paliperidone extended-release tablets are indicated for the treatment of schizoaffective disorder as monotherapy and an adjunct to mood stabilizers and/or antidepressant therapy [see clinical studies (14.2)] . the efficacy of paliperidone extended-release tablets in schizoaffective disorder was established in two 6-week trials in adults. paliperidone extended-release tablets are contraindicated in patients with a known hypersensitivity to either paliperidone or risperidone, or to any of the excipients in the paliperidone extended-release tablets formulation. hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported in patients t

United States - English - NLM (National Library of Medicine)

patriot pharmaceuticals - itraconazole (unii: 304nug5gf4) (itraconazole - unii:304nug5gf4) - itraconazole 100 mg - itraconazole capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: - blastomycosis, pulmonary and extrapulmonary - histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and - aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin b therapy. specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, antiinfective therapy should be adjusted accordingly. itraconazole capsules are also indicated for the treatment of the following fungal infections in non-immunocompromised patients: - onychomycosis of the toenail, with or without fingernail invol

United States - English - NLM (National Library of Medicine)

patriot pharmaceuticals llc - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol 5 mg in 1 ml - haloperidol is indicated for the treatment of patients with schizophrenia. haloperidol is contraindicated in patients with: - severe toxic central nervous system depression or comatose states from any cause. - hypersensitivity to this drug – hypersensitivity reactions have included anaphylactic reaction and angioedema (see warnings, hypersensitivity reactions and adverse reactions). - parkinson's disease (see warnings, neurological adverse reactions in patients with parkinson's disease or dementia with lewy bodies). - dementia with lewy bodies (see warnings, neurological adverse reactions in patients with parkinson's disease or dementia with lewy bodies).